AlgoNomics NV
http://www.algonomics.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From AlgoNomics NV
Lonza buys Belgian CRO Algonomics
Just days after calling off its planned acquisition of Patheon, reducing earnings guidance and announcing cost-cutting plans, Lonza has acquired the Belgian biotech contract research organisation, Algonomics. The price paid was not disclosed. Algonomics strengthens Lonza in protein design technology.
Recent Financings of Private Companies (07/2007)
Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.
Recent Dealmaking (04/2004)
Summarizing the month in European dealmaking.
Selected Start-Ups Founded in 2000 (0002)
{In Vivo} summarizes the technologies of several medical companies founded recently, including Belgium's [AlgoNomics NV], a new entrant in the biocomputing and bioinformatics arena. [CoPharma Inc.]'s mission is to develop drug and biological products through joint ventures with discovery firms. Launched in February 2000 with $2 million from Sanderling, Alta Partners and Graystone, [Cythera Inc.] will develop therapies based on the transplantation of functional human cells grown{ in vitro}, offering an alternative to the use of donated human tissues. [Embolic Protection Inc.] has developed a device, consisting of a guide wire and filter mechanism, to remove embolic debris. Denmark's [NsGene A/S] is a joint venture of NeuroSearch A/S and the University of Lund. [WebEBM] will offer evidence-based clinical guidelines for 400 diseases or conditions on its website.
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
-
Biotechnology
-
Large Molecule
- Antibodies
-
Drug Discovery Tools
- Bioinformatics
-
Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice